No Convertible Securities. Acquiror shall be satisfied, acting reasonably, that there will be no options, warrants or other rights (including any Company Options, Company Warrants or 6% Amortizing Convertible Notes) requiring the issuance of any securities of the Company or its Subsidiaries or any securities convertible into, or exchangeable for, or otherwise evidencing a right to acquire any securities of the Company or its Subsidiaries after giving effect to the Arrangement.
No Convertible Securities. Other than the Chelsian Note, the Non-Interest Bearing Convertible Securities, and the Interest Bearing Convertible Securities, there are no outstanding securities of BVT that are convertible, exchangeable, or redeemable into BVT Shares, including, without limitation, options, warrants or preferred shares.
No Convertible Securities. UQ has outstanding: (i) the UQ Options entitling their holders to purchase an aggregate of 900,000 pre-Consolidation UQ Shares at an exercise price of $0.15 per share, expiring on April 3, 2017, and (ii) the UQ Warrants entitling their holders to purchase an aggregate of 6,500,000 pre-Consolidation UQ Shares at an exercise price of $0.15 per UQ Share until March 30, 2017. Other than the UQ Options and the UQ Warrants, there are no outstanding securities of UQ that are convertible, exchangeable or redeemable into UQ Shares.
No Convertible Securities. Prior to the Closing Date, neither HMLF nor Acquisition Sub has authorized and does not have in effect any stock options or stock purchase plans, dividend reinvestment plans or similar plans pursuant to which any person is entitled to acquire capital stock of either HMLF or Acquisition Sub or any securities convertible into or exchangeable for its capital stock. No shares of capital stock of either HMLF or Acquisition Sub will be awarded or issued without the prior written authorization of MIT.
No Convertible Securities. Other than the SMAART Debentures the SMAART Warrants and the SMAART Options, there are no outstanding securities of SMAART or any SMAART Subsidiary that are convertible, exchangeable, or redeemable into SMAART Shares or securities of any SMAART Subsidiary, including, without limitation, options, warrants or preferred shares.
No Convertible Securities. Adira has outstanding the Adira Warrants, and there are no Adira Options outstanding. Other than the Adira Warrants, there are no outstanding securities of Adira that are convertible, exchangeable or redeemable into Adira Shares.
No Convertible Securities. For so long as Preferred Shares are outstanding and for so long as the Exercise Period has not expired or been terminated with respect to the Option Shares, the Company shall not, without the prior written consent of the Investors (a) sell or issue any of the Company's or any of its Subsidiaries preferred stock or any other securities convertible, exercisable or exchangeable into shares of Common Stock or preferred stock, or any rights, options or warrants to purchase any shares of its Common Stock, (b) issue or sell or agree to issue or sell any securities in a MFN Transaction (as defined below), or (c) issue or sell or agree to issue or sell any securities in a Variable Rate Transaction (as defined below), in each case other than shares or options issued pursuant to (i) the Company's current or future employee, director or bona fide consultant option plans, (ii) the exercise of options, warrants or rights outstanding on the date of this Agreement and listed in the Company's most recent periodic report filed under the 1934 Act, (iii) arrangements with all the holders of Preferred Shares, (iv) an underwriting agreement, to one or more underwriters in connection with a bona fide public offering (as defined in the Certificate), (v) strategic acquisitions of other entities by the Company which engage in businesses related or complementary to the Company's business, or (vi) an investment in the Company by another entity which engages in business(es) related or complementary to the Company's business. The term "MFN Transaction" shall mean a transaction in which the Company issues or sells any securities in a capital raising transaction or series of related transactions (the "New Offering") which grants to an investor (the "New Investor") the right to receive additional shares (including without limitation as a result of a lower conversion, exchange or exercise price) based upon subsequent transactions of the Company on terms more favorable than those granted to such New Investor in such New Offering. The term "Variable Rate Transaction" shall mean a transaction in which the Company issues or sells (a) any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (x) at a conversion, exercise or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance of such...
No Convertible Securities. There are no outstanding securities of Kungsleden that are convertible, exchangeable, or redeemable into Kungsleden Shares, including, without limitation, options, warrants or preferred shares.
No Convertible Securities. The Company shall have complied with its obligations pursuant to Section 6.21, and Acquirors shall be satisfied, acting reasonably, that there will be no options, warrants or other rights (including any Company Options) , requiring the issuance of any securities of the Company or its Subsidiaries or any securities convertible into, or exchangeable for, or otherwise evidencing a right to acquire any securities of the Company or its Subsidiaries after giving effect to the Arrangement.
No Convertible Securities. At the Effective Time, there shall not be any securities, rights, warrants, options or other instruments originally issued by AEL which, after consummation of the Merger, would be convertible into or exercisable for securities of the Surviving Corporation.